๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radical prostatectomy in the treatment of prostatic cancer

โœ Scribed by Ormond S. Culp; James J. Meyer


Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
447 KB
Volume
32
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The legitimate role of radical prostatectomy remains controversial. A prospective study was started at the Mayo Clinic in 1950 to evaluate therapeutic usefulness of the operation. Rigid criteria were established for selection of surgical candidates. From 1950 through 1972, 264 patients had radical prostatectomy for cancer at this clinic. Of 115 patients treated by radical perineal prostatectomy at least 10 years ago, 72% have lived from 10-21 years with 57% showing no clinical evidence of the disease. Of 74 patients operated on 15 or more years ago, 54% have survived for 15-21 years and 48% of these survivors appear to be cancer-free. Sue and grade of the adenocarcinoma in- fluenced survival. Endocrine therapy, which was deferred until development of recurrence or metastasis, may have increased longevity in some instances. Radical prostatectomy for cancer has both curative and palliative potentialities in properly selected cases. It should be utilized more frequently, rationally, and effectively.

ECAUSE OF THE VAGARIES OF PROSTATIC

B cancer, the legitimate role of total prostatectomy probably always will be controversial. Ever since Young14 performed his first radical perineal prostatectomy for this clinical chameleon in March 1904 with Halsted as his assistant, there have been innumerable "conscientious objectors." Several factors that have contributed to this antipathy include: (1) failure of many surgeons to master the precise technical demands of the procedure, even after the introduction of Millin'slo retropubic approach in 1945; (2) persistence of the thought that any clinically detectable prostatic cancer is already incurable; (3) promotion of conservative endocrinologic and radiologic management rather than of radical prostatic surgery; (4) unwillingness of patients to accept the physiologic price of either postoperative impotence or stress incontinence of urine or both; and (5) most disastrous of all, continuation of maldirected perineal and retropubic operations in improperly selected patients by poorly qualified surgeons.


๐Ÿ“œ SIMILAR VOLUMES


Role of radical prostatectomy in patient
โœ Tefilli, Marcos V.; Gheiler, Edward L.; Tiguert, Rabi; Banerjee, Mousumi; Sakr, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 201 KB ๐Ÿ‘ 1 views

## BACKGROUND. The routine use of serum prostate-specific antigen (PSA) testing combined with digital rectal examination has lowered tumor volume and clinical-pathological stage of men undergoing radical prostatectomy. Therefore, we may identify more men with poorly differentiated tumors of early

Results of hospital cancer registry surv
โœ Curtis J. Mettlin; Gerald P. Murphy; JoAnne Sylvester; Rosemary F. McKee; Monica ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 93 KB ๐Ÿ‘ 1 views

## Background: The number of prostate cancer patients treated by radical prostatectomy has increased. different data sources have yielded various estimates of the outcomes of this treatment and the need for additional therapy. to provide additional perspective on these issues, the american college

Workgroup 2: Staging and reporting of pr
โœ Wael A. Sakr; Thomas M. Wheeler; Michael Blute; Miklos Bodo; Rocio Calle-Rodrigu ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB ๐Ÿ‘ 1 views

he following document represents recommendations pertinent T only to a pathologic TNM staging system. This summary is not intended to debate the prognostic importance of any of the morphologic parameters listed (volume, multicentricity, zonal origin, etc.).

The surgery of prostate cancer: An updat
โœ Jason S. Krumholtz; Gerald L. Andriole ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 44 KB ๐Ÿ‘ 1 views

Prostate cancer is the most commonly diagnosed malignancy among men in the United States. Radical prostatectomy has been the gold standard for treating clinically localized prostate cancer. Its morbidity and disease-control capabilities have been well studied. At 10 years after surgery, 50% to 70% o